PHB1 and posterior cortical atrophy: The cytoplasmic delivery of siRNA-PHB1 with these nanoparticles (with different entrapment efficiencies from 51.8–92.1%) led to downregulation of this oncogene to about 60–90%, as well as a decrease in the malignancy of PCa cells [182].